"Antigens, Neoplasm" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.
| Descriptor ID |
D000951
|
| MeSH Number(s) |
D23.050.285
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antigens, Neoplasm".
Below are MeSH descriptors whose meaning is more specific than "Antigens, Neoplasm".
This graph shows the total number of publications written about "Antigens, Neoplasm" by people in this website by year, and whether "Antigens, Neoplasm" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 5 | 3 | 8 |
| 1996 | 4 | 1 | 5 |
| 1997 | 4 | 1 | 5 |
| 1998 | 3 | 3 | 6 |
| 1999 | 2 | 2 | 4 |
| 2000 | 1 | 4 | 5 |
| 2001 | 3 | 4 | 7 |
| 2002 | 2 | 3 | 5 |
| 2003 | 1 | 5 | 6 |
| 2004 | 4 | 5 | 9 |
| 2005 | 7 | 2 | 9 |
| 2006 | 5 | 8 | 13 |
| 2007 | 1 | 6 | 7 |
| 2008 | 5 | 6 | 11 |
| 2009 | 8 | 4 | 12 |
| 2010 | 4 | 2 | 6 |
| 2011 | 3 | 0 | 3 |
| 2012 | 11 | 1 | 12 |
| 2013 | 5 | 9 | 14 |
| 2014 | 7 | 7 | 14 |
| 2015 | 0 | 8 | 8 |
| 2016 | 4 | 2 | 6 |
| 2017 | 4 | 3 | 7 |
| 2018 | 5 | 3 | 8 |
| 2019 | 5 | 2 | 7 |
| 2020 | 5 | 4 | 9 |
| 2021 | 4 | 3 | 7 |
| 2022 | 1 | 3 | 4 |
| 2023 | 1 | 3 | 4 |
| 2024 | 2 | 3 | 5 |
| 2025 | 4 | 2 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antigens, Neoplasm" by people in Profiles.
-
Dendritic cell-derived exosomes induce monocyte antigen-presentation and immune amplification in neoantigen vaccine therapy. Front Immunol. 2025; 16:1565696.
-
Bispecific antibody targeting shared indel-derived neoantigen of APC. Front Immunol. 2025; 16:1574958.
-
Identification of shared neoantigens derived from frameshift mutations in the APC gene. Front Immunol. 2025; 16:1574955.
-
Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoire. J Immunother Cancer. 2025 May 02; 13(5).
-
Neoantigen peptide-pulsed dendritic cell vaccine therapy after surgical treatment of pancreatic cancer: a retrospective study. Front Immunol. 2025; 16:1571182.
-
mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumors. J Immunother Cancer. 2025 Mar 25; 13(3).
-
PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial. Nat Commun. 2024 12 30; 15(1):10743.
-
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs. Cancer Immunol Res. 2024 Oct 01; 12(10):1421-1437.
-
One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication. Clin Cancer Res. 2024 Apr 15; 30(8):1642-1654.
-
Cysteine-binding adjuvant enhances survival and promotes immune function in a murine model of acute myeloid leukemia. Blood Adv. 2024 04 09; 8(7):1747-1759.